John W. Kozarich, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 934 shares at $131.88 ($123K) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Scheduled sale ($123k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.88 | 467 | $62K | 50.0% |
| 2 | $131.88 | 467 | $62K | 50.0% |
| Total | $131.88 avg | 934 | $123K | 100% |
| Filing → |
| LGND | SELL | 2026-03-04 | $179K | — | Filing → |
| LGND | SELL | 2026-02-04 | $175K | — | Filing → |
| LGND | SELL | 2026-01-06 | $173K | — | Filing → |